Yangtze River Pharmaceutical Group Beijing Haiyan Pharmaceutical

Beijing Haiyan Pharmaceutical is a prominent subsidiary of the Yangtze River Pharmaceutical Group (YRPG), based in Beijing's Zhongguancun Life Science Park. Established as a key R&D and manufacturing hub, the company specializes in the development of high-end generic drugs and innovative medicines across diverse therapeutic fields such as cardiology, gastroenterology, and infectious diseases. Beijing Haiyan operates state-of-the-art production lines that adhere to international GMP standards, supporting YRPG's position as a leader in the Chinese pharmaceutical industry. The company's portfolio includes widely used treatments like dexlansoprazole and ticagrelor, reflecting its commitment to providing affordable and effective healthcare solutions. As a National High-tech Enterprise, it plays a vital role in the group's innovation strategy and regional expansion.